Concepedia

Author

Shudong Wang

University of South AustraliaORCID

Also Known As

C Fallan, Chuanhua Kou, S Wang, Shelley Xuelai Wang, Shu-Dong WANG, Shu-Dong Wang, Shu-dong Wang, Shudong Wang, Wang S, Wang Shudong

230

Publications

5.3K

Citations

40

H-Index

87

Concepts

All Affiliations

University of South AustraliaUniversity of NottinghamCyclacel Pharmaceuticals (United Kingdom)Centre for Cancer BiologyUniversity of Edinburgh
SW

About

Shudong Wang is an author at University of South Australia specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

42

1.8K

2

Natural Sciences

16

19

1.1K

3

Biochemistry

13

15

894

4

Engineering

6

6

94

5

Health Sciences

2

2

66

Shudong Wang

×

75

Publications

3.3K

Citations

32

H-Index

YearCitations

<i>In vitro</i> and <i>in vivo</i> antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R‐roscovitine)

Steven J. McClue, David Blake, Rosemary G. Clarke,

International Journal of Cancer

2002

363

2-Anilino-4-(thiazol-5-yl)pyrimidine CDK Inhibitors:  Synthesis, SAR Analysis, X-ray Crystallography, and Biological Activity

Shudong Wang, Christopher Meades, Gavin Wood,

Journal of Medicinal Chemistry

2004

151

Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities

Hao Shao, Shenhua Shi, Shi‐Liang Huang,

Journal of Medicinal Chemistry

2013

121

Utilization of Halogen Bond in Lead Optimization: A Case Study of Rational Design of Potent Phosphodiesterase Type 5 (PDE5) Inhibitors

Zhijian Xu, Zheng Liu, Tong Chen,

Journal of Medicinal Chemistry

2011

120

Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUS

S. Y. Wu, I.W. McNae, George Kontopidis,

Structure

2003

105

Discovery and Characterization of 2-Anilino-4- (Thiazol-5-yl)Pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents

Shudong Wang, Gary Griffiths, Carol Midgley,

Chemistry & Biology

2010

101

Discovery of<i>N</i>-Phenyl-4-(thiazol-5-yl)pyrimidin-2-amine Aurora Kinase Inhibitors

Shudong Wang, Carol Midgley, Frédéric Scaërou,

Journal of Medicinal Chemistry

2010

100

New Lupane Derived Compounds with Pro-Apoptotic Activity in Cancer Cells:  Synthesis and Structure−Activity Relationships

Jan Šarek, Jiří Klinot, Petr Džubák,

Journal of Medicinal Chemistry

2003

87

A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine

Elisabeth Walsby, Guy Pratt, Hao Shao,

Oncotarget

2013

82

Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3<i>H</i>)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation

Sarah Diab, Theodosia Teo, Malika Kumarasiri,

ChemMedChem

2014

80

Page 1